Susan F. Leitman focuses on Immunology, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Stem cell. Her study in Immunology is interdisciplinary in nature, drawing from both Haematopoiesis and Genetic enhancement, Gene. Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.
As part of the same scientific family, she usually focuses on Hematopoietic stem cell transplantation, concentrating on Fludarabine and intersecting with Donor Lymphocytes, Preparative Regimen and Transplantation Chimera. Her Surgery research focuses on subjects like Leukapheresis, which are linked to Apheresis and Platelet transfusion. Susan F. Leitman combines subjects such as Transplantation Conditioning and Leukemia with her study of Transplantation.
Her primary areas of investigation include Immunology, Internal medicine, Transplantation, Surgery and Gastroenterology. The study incorporates disciplines such as Hematopoietic stem cell transplantation, Stem cell and Leukapheresis in addition to Immunology. Her research investigates the connection between Internal medicine and topics such as Endocrinology that intersect with problems in Anemia.
Susan F. Leitman has included themes like Hematopoietic cell, Transplantation Conditioning and Leukemia in her Transplantation study. In her research on the topic of Surgery, Hemochromatosis is strongly related with Ferritin. Her work on Chemotherapy expands to the thematically related Gastroenterology.
Susan F. Leitman mainly focuses on Internal medicine, Immunology, Surgery, Transplantation and Gastroenterology. Internal medicine connects with themes related to CD34 in her study. Her research in Immunology intersects with topics in Hematopoietic stem cell transplantation and Neutropenia.
Her work deals with themes such as Anesthesia, Pagophagia, Pica, Quality of life and Platelet, which intersect with Surgery. Her Transplantation research is multidisciplinary, incorporating perspectives in Urology, Myeloid, Leukapheresis, Transplantation Conditioning and Apheresis. Her biological study spans a wide range of topics, including Cyclophosphamide and Fludarabine.
Susan F. Leitman mostly deals with Internal medicine, Immunology, Surgery, Transplantation and Bone marrow. Her study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Promoter, Chromatin immunoprecipitation. Her Surgery research incorporates themes from Hereditary hemochromatosis, Quality of life, Pagophagia and Pica.
Her work deals with themes such as CD34, Peripheral blood mononuclear cell, Transplant Conditioning and Sickle cell trait, which intersect with Transplantation. Her studies in Bone marrow integrate themes in fields like Prospective cohort study and Stem cell. She interconnects Carfilzomib, Lenalidomide, Oncology and Minimal residual disease in the investigation of issues within Stem cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.
Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Alfred E. Chang.
The New England Journal of Medicine (1987)
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Susan Leitman.
The New England Journal of Medicine (1985)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley;James C. Yang;Richard Sherry;Marybeth S. Hughes.
Journal of Clinical Oncology (2008)
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Childs R;Chernoff A;Contentin N;Bahceci E.
The New England Journal of Medicine (2000)
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Toshihiko Tanno;Natarajan V Bhanu;Patricia A Oneal;Sung-Ho Goh.
Nature Medicine (2007)
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller.
The New England Journal of Medicine (2012)
Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer
Steven A. Rosenberg;Michael T. Lotze;James C. Yang;Suzanne L. Topalian.
Journal of the National Cancer Institute (1993)
Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.
Susan J Perlmutter;Susan F Leitman;Marjorie A Garvey;Susan Hamburger.
The Lancet (1999)
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.
R. Childs;E. Clave;N. Contentin;D. Jayasekera.
CCR5 promoter polymorphism and HIV-1 disease progression
David H McDermott;Peter A Zimmerman;Peter A Zimmerman;Florence Guignard;Cynthia A Kleeberger.
The Lancet (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: